This project aims at exploring three novel non-invasive technologies: 13C-breath tests (stable-isotope-based liver-targeted substrates), sugar absorption tests (urinary HPLC-based) intestinal permeability and mid-range infra-red fingerprinting of urine and plasma samples, to evaluate Non-Alcoholic Fatty Liver Disease (NAFLD) staging.
Research will include methodologies for developing and applying novel biomarker algorithms for NAFLD diagnosis and staging based on the three novel technologies. The post-holder will have some scope to adapt the project based on their interests.
University of Bari Aldo Moro (UNIBA), Italy.
Dr. Piero Portincasa
Center for Neuroscience and Cell Biology (CNC), Portugal
Dr. Martin Winter
Dr. Paulo Oliveira
Dr. John Jones